On the other hand, Jason R. Cook and colleagues reported that a TGF-β neutralizing antibody was harmful at the early stage of Marfan syndrome and proposed that TGF-β might play completely different roles during disease progression [10]. This evidence concerns the gene TGFB1 and Marfan syndrome.